The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?

od Ilyas, Sumera I., Borad, Mitesh J.
Izdano u J Gastrointest Oncol (2016)

Advances in systemic therapy for advanced pancreatobiliary malignancies

od Halfdanarson, Thorvardur R, Haraldsdottir, Sigurdis, Borad, Mitesh J
Izdano 2013

Hypoxia-Activated Alkylating Agents in BRCA1-Mutant Ovarian Serous Carcinoma

od Conroy, Michael, Borad, Mitesh J, Bryce, Alan H
Izdano u Cureus (2017)

Oncolytic Adenoviruses in Gastrointestinal Cancers

od Yokoda, Raquel T., Nagalo, Bolni M., Borad, Mitesh J.
Izdano u Biomedicines (2018)

Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma

od Borad, Mitesh J., Gores, Gregory J., Roberts, Lewis R.
Izdano u Curr Opin Gastroenterol (2015)

Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities

od Rizvi, Sumera, Borad, Mitesh J., Patel, Tushar, Gores, Gregory J.
Izdano u Semin Liver Dis (2014)

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma

od Babiker, Hani M, Riaz, Irbaz Bin, Husnain, Muhammad, Borad, Mitesh J
Izdano u Oncolytic Virother (2017)

Immunotherapy in pancreatic cancer treatment: a new frontier

od Thind, Komal, Padrnos, Leslie J., Ramanathan, Ramesh K., Borad, Mitesh J.
Izdano u Therap Adv Gastroenterol (2016)

FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice

od Kommalapati, Anuhya, Tella, Sri Harsha, Borad, Mitesh, Javle, Milind, Mahipal, Amit
Izdano u Cancers (Basel) (2021)

Recent advances in understanding cholangiocarcinoma

od Uson Junior, Pedro Luiz Serrano, Arora, Mansi, Bogenberger, James M, Borad, Mitesh J
Izdano u Fac Rev (2020)

Emerging role of precision medicine in biliary tract cancers

od Bogenberger, James M., DeLeon, Thomas T., Arora, Mansi, Ahn, Daniel H., Borad, Mitesh J.
Izdano u NPJ Precis Oncol (2018)

Evolving Role of Oncolytic Virotherapy: Challenges and Prospects in Clinical Practice

od Moaven, Omeed, W. Mangieri, Christopher, A. Stauffer, John, Anastasiadis, Panos Z., Borad, Mitesh J.
Izdano u JCO Precis Oncol (2021)

Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy

od Moaven, Omeed, Mangieri, Christopher W., Stauffer, John A., Anastasiadis, Panos Z., Borad, Mitesh J.
Izdano u JCO Precis Oncol (2021)

Marantic Endocarditis Associated with Pancreatic Cancer: A Case Series

od Jameson, Gayle S., Ramanathan, Ramesh K., Borad, Mitesh J., Downhour, Molly, Korn, Ronald, Von Hoff, Daniel
Izdano 2009

Perspectives on immunotherapy utilization for hepatobiliary cancers in the United States

od Usón Junior, Pedro Luiz Serrano, Ahn, Daniel, Sonbol, Mohamad Bassam, Bekaii-Saab, Tanios, Borad, Mitesh J.
Izdano u Hepatobiliary Surg Nutr (2020)

Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma()()()

od Zakharia, Kais, Miyabe, Katsuyuki, Wang, Yu, Wu, Dehai, Moser, Catherine D., Borad, Mitesh J., Roberts, Lewis R.
Izdano u Transl Oncol (2018)

Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups

od Asmann, Yan W., Parikh, Kaushal, Bergsagel, P. Leif, Dong, Haidong, Adjei, Alex A., Borad, Mitesh J., Mansfield, Aaron S.
Izdano u NPJ Precis Oncol (2021)

Portal Vein Embolization: Impact of Chemotherapy and Genetic Mutations

od Deipolyi, Amy R., Zhang, Yu Shrike, Khademhosseini, Ali, Naidu, Sailendra, Borad, Mitesh, Sahin, Burcu, Mathur, Amit K., Oklu, Rahmi
Izdano u J Clin Med (2017)

Using Naïve Bayesian Analysis to Determine Imaging Characteristics of KRAS Mutations in Metastatic Colon Cancer

od Pershad, Yash, Govindan, Siddharth, Hara, Amy K., Borad, Mitesh J., Bekaii-Saab, Tanios, Wallace, Alex, Albadawi, Hassan, Oklu, Rahmi
Izdano u Diagnostics (Basel) (2017)

MetaMarker: a pipeline for de novo discovery of novel metagenomic biomarkers

od Koohi-Moghadam, Mohamad, Borad, Mitesh J, Tran, Nhan L, Swanson, Kristin R, Boardman, Lisa A, Sun, Hongzhe, Wang, Junwen
Izdano u Bioinformatics (2019)